Aurobindo Pharma has announced that it has reached a definitive agreement to sell its subsidiary – Natrol LLC to New Mountain Capital, which will combine it with Jarrow Formulas. This transaction is expected to close by January 2021 subject to customary closing conditions and regulatory approvals. The pharma firm is looking to use the proceeds…
Novartis today announced it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo Pharma USA Inc., for USD 0.9 billion of cash plus USD 0.1 billion of potential earn-outs. This transaction supports the Sandoz strategy of focusing on complex…